Mesenchymal Stromal Cells and Their Secretome: New Therapeutic Perspectives for Skeletal Muscle Regeneration

Martina Sandonà 1
Lorena Di Pietro 2
Federica Esposito 1
Alessia Ventura 1
Antonietta Rosa Silini 3
Ornella Parolini 2, 4
Valentina Saccone 1, 2
Publication typeJournal Article
Publication date2021-05-13
scimago Q1
wos Q1
SJR0.974
CiteScore8.8
Impact factor4.8
ISSN22964185
Biotechnology
Bioengineering
Histology
Biomedical Engineering
Abstract

Mesenchymal stromal cells (MSCs) are multipotent cells found in different tissues: bone marrow, peripheral blood, adipose tissues, skeletal muscle, perinatal tissues, and dental pulp. MSCs are able to self-renew and to differentiate into multiple lineages, and they have been extensively used for cell therapy mostly owing to their anti-fibrotic and immunoregulatory properties that have been suggested to be at the basis for their regenerative capability. MSCs exert their effects by releasing a variety of biologically active molecules such as growth factors, chemokines, and cytokines, either as soluble proteins or enclosed in extracellular vesicles (EVs). Analyses of MSC-derived secretome and in particular studies on EVs are attracting great attention from a medical point of view due to their ability to mimic all the therapeutic effects produced by the MSCs (i.e., endogenous tissue repair and regulation of the immune system). MSC-EVs could be advantageous compared with the parental cells because of their specific cargo containing mRNAs, miRNAs, and proteins that can be biologically transferred to recipient cells. MSC-EV storage, transfer, and production are easier; and their administration is also safer than MSC therapy. The skeletal muscle is a very adaptive tissue, but its regenerative potential is altered during acute and chronic conditions. Recent works demonstrate that both MSCs and their secretome are able to help myofiber regeneration enhancing myogenesis and, interestingly, can be manipulated as a novel strategy for therapeutic interventions in muscular diseases like muscular dystrophies or atrophy. In particular, MSC-EVs represent promising candidates for cell free-based muscle regeneration. In this review, we aim to give a complete picture of the therapeutic properties and advantages of MSCs and their products (MSC-derived EVs and secreted factors) relevant for skeletal muscle regeneration in main muscular diseases.

Found 
Found 

Top-30

Journals

1
2
3
4
5
6
7
8
9
International Journal of Molecular Sciences
9 publications, 11.11%
Frontiers in Cell and Developmental Biology
4 publications, 4.94%
Biomedicines
3 publications, 3.7%
Cells
2 publications, 2.47%
Stem Cell Research and Therapy
2 publications, 2.47%
Stem Cells
2 publications, 2.47%
Bioengineering
2 publications, 2.47%
Advanced Science
2 publications, 2.47%
Human Cell
1 publication, 1.23%
Stem Cells and Development
1 publication, 1.23%
World Journal of Stem Cells
1 publication, 1.23%
Frontiers in Physiology
1 publication, 1.23%
Stem Cell Reviews and Reports
1 publication, 1.23%
Respiratory Research
1 publication, 1.23%
Biochimie
1 publication, 1.23%
Cell Biology and Toxicology
1 publication, 1.23%
Regenerative Engineering and Translational Medicine
1 publication, 1.23%
Cell Proliferation
1 publication, 1.23%
Cell Death and Disease
1 publication, 1.23%
Biochemical and Biophysical Research Communications
1 publication, 1.23%
Methods in Molecular Biology
1 publication, 1.23%
Biomolecules
1 publication, 1.23%
Oral Diseases
1 publication, 1.23%
Brain Research Bulletin
1 publication, 1.23%
Journal of Controlled Release
1 publication, 1.23%
Journal of Maternal-Fetal and Neonatal Medicine
1 publication, 1.23%
Nature Communications
1 publication, 1.23%
Inflammation and Regeneration
1 publication, 1.23%
Aging Cell
1 publication, 1.23%
1
2
3
4
5
6
7
8
9

Publishers

2
4
6
8
10
12
14
16
18
MDPI
17 publications, 20.99%
Springer Nature
15 publications, 18.52%
Elsevier
15 publications, 18.52%
Wiley
10 publications, 12.35%
Frontiers Media S.A.
6 publications, 7.41%
Oxford University Press
3 publications, 3.7%
Research Square Platform LLC
3 publications, 3.7%
Cold Spring Harbor Laboratory
2 publications, 2.47%
Taylor & Francis
2 publications, 2.47%
Mary Ann Liebert
1 publication, 1.23%
Baishideng Publishing Group
1 publication, 1.23%
Ovid Technologies (Wolters Kluwer Health)
1 publication, 1.23%
OAE Publishing Inc.
1 publication, 1.23%
SAGE
1 publication, 1.23%
Federation of American Societies for Experimental Biology (FASEB)
1 publication, 1.23%
2
4
6
8
10
12
14
16
18
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
81
Share
Cite this
GOST |
Cite this
GOST Copy
Sandonà M. et al. Mesenchymal Stromal Cells and Their Secretome: New Therapeutic Perspectives for Skeletal Muscle Regeneration // Frontiers in Bioengineering and Biotechnology. 2021. Vol. 9.
GOST all authors (up to 50) Copy
Sandonà M., Di Pietro L., Esposito F., Ventura A., Silini A. R., Parolini O., Saccone V. Mesenchymal Stromal Cells and Their Secretome: New Therapeutic Perspectives for Skeletal Muscle Regeneration // Frontiers in Bioengineering and Biotechnology. 2021. Vol. 9.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.3389/fbioe.2021.652970
UR - https://doi.org/10.3389/fbioe.2021.652970
TI - Mesenchymal Stromal Cells and Their Secretome: New Therapeutic Perspectives for Skeletal Muscle Regeneration
T2 - Frontiers in Bioengineering and Biotechnology
AU - Sandonà, Martina
AU - Di Pietro, Lorena
AU - Esposito, Federica
AU - Ventura, Alessia
AU - Silini, Antonietta Rosa
AU - Parolini, Ornella
AU - Saccone, Valentina
PY - 2021
DA - 2021/05/13
PB - Frontiers Media S.A.
VL - 9
PMID - 34095095
SN - 2296-4185
ER -
BibTex
Cite this
BibTex (up to 50 authors) Copy
@article{2021_Sandonà,
author = {Martina Sandonà and Lorena Di Pietro and Federica Esposito and Alessia Ventura and Antonietta Rosa Silini and Ornella Parolini and Valentina Saccone},
title = {Mesenchymal Stromal Cells and Their Secretome: New Therapeutic Perspectives for Skeletal Muscle Regeneration},
journal = {Frontiers in Bioengineering and Biotechnology},
year = {2021},
volume = {9},
publisher = {Frontiers Media S.A.},
month = {may},
url = {https://doi.org/10.3389/fbioe.2021.652970},
doi = {10.3389/fbioe.2021.652970}
}